Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
AST SpaceMobile and Rocket Lab fell roughly 4% intraday, then clawed back losses as markets rotated amid a volatile w...
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
Cardano has weathered wild crypto cycles before. This guide lays out credible scenarios for 2030, explains what could...
Solana stands at a turning point as SOL tests a key price band. Traders are watching resistance near the $100 mark an...
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
Bitcoin faces renewed pressure as macro forces and a looming liquidity drain weigh on prices. Analysts warn that the ...
CoreWeave faces a split verdict as revenue surges and debt refinancing looms. The market must decide whether it becom...
Trex teams up with Martha Stewart to propel upscale outdoor living, launching a collaborative content push anchored b...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
A top research firm issues the highest conviction call realty on Realty Income, setting a bold price target as the RE...
Netflix trades below $78 as investors weigh ad-supported growth and margin targets. Analysts dispute whether the stoc...